| 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI) |
775351-65-0 |
775351-65-0 |
| Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
| DG172 (dihydrochloride) |
1361504-77-9 |
1361504-77-9 |
| SJB2-043 |
SJB2-043 |
63388-44-3 |
| ML264 |
(2E)-3-(3-氯苯基)-N-[2-[甲基(四氢-1,1-二氧代-2H-噻喃-4-基)氨基]-2-氧代乙基]-2-丙烯酰胺 |
1550008-55-3 |
| GV-58 |
(2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇 |
1402821-41-3 |
| ME0328 |
ME0328 |
1445251-22-8 |
| GlyT2-IN-1 |
CS-2063 |
448947-81-7 |
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
| ROR gamma-t-IN-1 |
N-(2,6-二氯-2'-(三氟甲氧基)-[1,1'-联苯]-4-基)-2-(4-(乙基磺酰基)苯基)乙酰胺 |
1426802-50-7 |
| PRL-3 INHIBITOR I |
PRL-3 INHIBITOR I |
893449-38-2 |
| NS 1738 |
501684-93-1 |
501684-93-1 |
| N3PT |
3-[(2-氨基-6-甲基-3-吡啶基)甲基]-5-(2-羟基乙基)-4-甲基噻唑氯化物盐酸盐 |
13860-66-7 |
| NBI-74330 |
N-[(1R)-1-[3-(4-乙氧基苯基)-3,4-二氢-4-氧代吡啶并[2,3-D]嘧啶-2-基]乙基]-4-氟-N-(3-吡啶基甲基)-3-(三氟甲基)苯乙酰胺 |
855527-92-3 |
| MP-412 |
AV-412 |
451492-95-8 |
| 5'-ISOBUTYLTHIO-5'-DEOXYADENOSINE |
5ˊ-异丁硫基-5ˊ-脱氧腺苷 |
35899-54-8 |
| Frentizole |
夫仑替唑 |
26130-02-9 |
| C75 |
反-4-羧基-5-辛基-3-甲基-丁内酯 |
191282-48-1 |
| ATN-161 |
262438-43-7 |
262438-43-7 |
| 3-Amino-N-(4-methoxybenzyl)-4,6-dimethylthieno[2,3-b]pyridinecarboxamide |
3-氨基-N-[(4-甲氧基苯基)甲基]-4,6-二甲基噻吩并[2,3-B]吡啶-2-甲酰胺 |
409351-28-6 |
